Cell surface expression of GluR5 kainate receptors is regulated by an endoplasmic reticulum retention signal

被引:55
|
作者
Ren, Z
Riley, NJ
Needleman, LA
Sanders, JM
Swanson, GT
Marshall, J
机构
[1] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA
[2] Brown Univ, Dept Neurosci, Providence, RI 02912 USA
[3] Univ Texas, Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA
关键词
D O I
10.1074/jbc.M309585200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Kainate receptors (KARs) are mediators of excitatory neurotransmission in the mammalian central nervous system, and their efficient targeting and trafficking is critical for normal synaptic function. A key step in the delivery of KARs to the neuronal plasma membrane is the exit of newly assembled receptors from the endoplasmic reticulum (ER). Here we report the identification of a novel ER retention signal in the alternatively spliced C-terminal domain of the GluR5-2b subunit, which controls receptor trafficking in both heterologous cells and neurons. The ER retention motif consists of a critical arginine (Arg-896) and surrounding amino acids, disruption of which promotes ER exit and surface expression of the receptors, as well as altering their physiological properties. The Arg-896-mediated ER retention of GluR5 is regulated by a mutation that mimics phosphorylation of Thr-898, but not by PDZ interactions. Furthermore, two positively charged residues (Arg-900 and Lys-901) in the C terminus were also found to regulate ER export of the receptors. Taken together, our results identify novel trafficking signals in the C-terminal domain of GluR5-2b and demonstrate that alternative splicing is an important mechanism regulating KAR function.
引用
收藏
页码:52700 / 52709
页数:10
相关论文
共 50 条
  • [1] GluR5 kainate receptors, seizures, and the amygdala
    Rogawski, MA
    Gryder, D
    Castaneda, D
    Yonekawa, W
    Banks, MK
    Li, H
    AMYGDALA IN BRAIN FUNCTION: BACIC AND CLINICAL APPROACHES, 2003, 985 : 150 - 162
  • [2] Cell surface expression of 5-hydroxytryptamine type 3 receptors is controlled by an endoplasmic reticulum retention signal
    Boyd, GW
    Doward, AI
    Kirkness, EF
    Millar, NS
    Connolly, CN
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (30) : 27681 - 27687
  • [3] Role of AMPA and GluR5 kainate receptors in the development and expression of amygdala kindling in the mouse
    Rogawski, MA
    Kurzman, PS
    Yamaguchi, S
    Li, H
    NEUROPHARMACOLOGY, 2001, 40 (01) : 28 - 35
  • [4] Heteromeric kainate receptors formed by the coassembly of GluR5, GluR6, and GluR7
    Cui, CH
    Mayer, ML
    JOURNAL OF NEUROSCIENCE, 1999, 19 (19): : 8281 - 8291
  • [5] Deletion of the GluR5 subunit of kainate receptors affects cocaine sensitivity and preference
    Gregus, Ann M.
    Tropea, Thomas F.
    Wang, Yanran
    Hauck, Stefanie C. R.
    Costa, Alberto C. S.
    Rajadhyaksha, Anjali M.
    Inturrisi, Charles E.
    NEUROSCIENCE LETTERS, 2010, 468 (03) : 186 - 189
  • [6] Paradoxical anti-epileptic effects of a GluR5 agonist of kainate receptors
    Khalilov, I
    Hirsch, J
    Cossart, R
    Ben-Ari, Y
    JOURNAL OF NEUROPHYSIOLOGY, 2002, 88 (01) : 523 - 527
  • [7] [3H]ATPA:: a high affinity ligand for GluR5 kainate receptors
    Hoo, K
    Legutko, B
    Rizkalla, G
    Deverill, M
    Hawes, CR
    Ellis, GJ
    Stensbold, TB
    Krogsgaard-Larsen, P
    Skolnick, P
    Bleakman, D
    NEUROPHARMACOLOGY, 1999, 38 (12) : 1811 - 1817
  • [8] Identification of amino acid residues that control functional behavior in GluR5 and GluR6 kainate receptors
    Swanson, GT
    Gereau, RW
    Green, T
    Heinemann, SF
    NEURON, 1997, 19 (04) : 913 - 926
  • [9] GluR5 and GluR6 kainate receptor subunits coexist in hippocampal neurons and coassemble to form functional receptors
    Paternain, AV
    Herrera, MT
    Nieto, MA
    Lerma, J
    JOURNAL OF NEUROSCIENCE, 2000, 20 (01): : 196 - 205
  • [10] The role of kainate (GluR5) receptors in sensory responses of rat ventrobasal thalamus (VB) neurones
    Binns, KE
    Turner, JP
    Salt, TE
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135